Oppenheimer Downgrades IBM as Stock Plunges 25% in Single Day Before Slight Premarket Rebound
Taylor Wilson
IBM shares plunged 25% in a single session — the worst day in company history — after preliminary Q2 results missed on both earnings and revenue; Oppenheimer downgraded to neutral, but most Wall Street analysts still rate the stock a buy, and that split itself is a risk signal.
What exactly happened?
IBM released preliminary Q2 results: adjusted EPS of $2.93 and revenue of $17.2 billion, both well below the FactSet consensus of $3.01 and $17.86 billion.
This means → both core metrics missed at once, breaking the market's confidence in IBM's growth narrative in a single stroke.
Shares fell 25% on Tuesday — IBM's worst single-day drop ever. The stock edged up just 1.5% in pre-market the next day, with no clear sign of bargain-hunting.
Why did Oppenheimer downgrade now?
Oppenheimer cut IBM from "outperform" to "perform" (neutral), setting no price target.
Analyst Param Singh wrote: "The bull case will take longer to play out," and he expects the stock to trade range-bound in the near term.
He added that while Red Hat, HashiCorp, Confluent, and server/storage units offer bright spots, hitting full-year guidance — or achieving "double-digit" constant-currency software growth in 2026–2027 — will be difficult.
In plain terms = the positives exist, but they are not enough to underwrite the full-year targets. Oppenheimer is stepping to the sideline.
What does the rest of Wall Street think?
Oppenheimer's downgrade runs against the broader consensus. Per LSEG data, of 26 analysts covering IBM, 16 rate it buy or strong buy; only 9 hold.
This means → the majority is still bullish, but if IBM's results keep disappointing, those buy ratings become room for further downgrades — the more consensus clusters on one side, the harder the swing when it turns.
Why did results miss?
CEO Arvind Krishna explained: customers are redirecting capital spending toward servers, storage, and memory chips — AI infrastructure — locking in supply-constrained hardware ahead of expected price increases.
In plain terms = the money didn't vanish; it shifted to AI hardware first, crowding out mainframe and related software budgets.
The direct hit: infrastructure revenue fell 7%, with the z17 mainframe shortfall especially stark. IBM shares are now down roughly 27% year-to-date.
What comes next?
IBM is scheduled to report full quarterly results on July 22. Management's stance on full-year guidance will be the decisive moment.
This reflects what the market truly needs — not an explanation, but numbers: whether guidance is maintained, cut, or withdrawn will settle whether Oppenheimer's caution or Wall Street's bullish majority is right.
Content is for reference only, not financial advice.